Clinical guidelines, evidence-based calculators, current guideline resources.
⚕️ Information: This page is for healthcare professionals only. The content is a reference for clinical decision support; It does not replace the clinician's patient-specific assessment.
Interactive algorithms that provide step-by-step approach, treatment and drug dose recommendations by selecting disease and clinical criteria.
mWHO risk class, approach, drug dosage and delivery plan for 59 clinical conditions in congenital heart disease, aortopathy, pulmonary hypertension, valve disease, cardiomyopathy, arrhythmia, hypertensive and thromboembolic conditions.
Suspicion and diagnosis, etiological evaluation, follow-up and timing of birth according to Doppler finding, concomitant conditions, intrapartum management and prevention in subsequent pregnancy: 14 clinical pictures are selected together, the result in one unified card.
In-depth cited clinical reviews from ACOG, RCOG, NICE, SMFM, Cochrane and UpToDate.
Hypothyroidism and hyperthyroidism on one page: TSH thresholds, levothyroxine dose escalation, PTU–methimazole selection, TRAb-based fetal monitoring, thyroid storm and postpartum thyroiditis.
Diagnostic methods based on history, ultrasound and physical examination; thresholds and pitfalls of cervical length measurement; The evidence base for the choice between vaginal progesterone and cerclage.
PPH management from cumulative blood loss threshold to uterotonic doses, from the first three hour rule of tranexamic acid to massive transfusion targets.
Differentiation of normal course and warning signs in puerperium, timing of follow-up, mental health and cardiometabolic screening, choice of contraceptive method in breastfeeding women.
PROM management, from the false positive problem of biomarker tests to latency antibiotic regimens and the 34–37 week birth timing debate.
Timing and success determinants of ECV in term breech presentation, evidence base for the decision on mode of delivery, and criteria and technique of vaginal breech delivery in selected cases.
Summary of background risk, critical developmental windows, removal of FDA letter categories, pharmacokinetics in pregnancy, and commonly used drug groups.
Guideline-based summary of vertical transmission rates, where screening decisions differ by institution, prenatal diagnosis timing, and treatment thresholds.
CRL 7 mm and sac 25 mm thresholds, waiting–medication–surgery comparison, institution differentiation in anti-D decision, and recurrent pregnancy loss workup panel.
From diagnostic criteria and hCG elevation rate to methotrexate protocols, from the choice of salpingostomy–salpingectomy to interstitial and cesarean scar pregnancy.
Guideline-based management of induction, from cervical ripening doses to oxytocin regimens, from the ARRIVE discussion to the decision to induce at 41 weeks.
Summary of AFI and SDP thresholds, impact of measurement method on induction rate, etiology, amnioreduction, and birth timing decisions.
First-trimester combined (double), quadruple, and NIPT methods and performance; side-by-side guideline comparison (ACOG/NICE/SMFM/ISPD/ACMG); positive NIPT → invasive confirmation; Salomon 2019 updated procedure-related loss risk; GRADE certainty summary.
Diagnostic criteria, sFlt-1/PlGF pathophysiology, low-dose aspirin prophylaxis, MgSO4 seizure prophylaxis, acute antihypertensives and timing of birth.
One-step 75g and two-step 50g/100g screening, diagnostic thresholds, glycemic targets, insulin/oral agents, fetal monitoring and postpartum screening.
36 0/7–37 6/7 weeks screening, intrapartum antibiotic indications, penicillin regimens and penicillin allergy algorithm.
Trimester-based hemoglobin thresholds, differential diagnosis, oral and intravenous iron therapy, ferritin threshold and transfusion indications.
Hypercoagulability in pregnancy, RCOG risk scoring, LMWH doses, mechanical prophylaxis and timing of neuraxial anesthesia.
Delphi consensus definition, etiology, Doppler assessment (umbilical/MCA/CPR/ductus venosus), and timing of birth according to Doppler finding.
Cervical length/fFN, vaginal progesterone and cerclage, antenatal corticosteroids, MgSO4 neuroprotection and tocolytic selection.
Screening, event-based anti-D Ig doses and timing, MCA-PSV monitoring in sensitized pregnancy, and fetal RHD genotyping.
Safely reducing primary cesarean section, TOLAC candidate selection, prediction of success, risk of uterine rupture, and placenta accreta spectrum.
Initial visit panel, visit schedule (traditional/telehealth), aneuploidy screening (cfDNA/NIPT), anomaly screening, and routine testing schedule.
Guideline-based, evidence-based obstetrics calculation tools. Methods, sources, and limitations are documented in each.
Physician assessment for high and intermediate risk factors, missing information, and aspirin appropriateness.
Review the period, risks, and special assessment requirement using the Department and RCOG tables separately.
Gestational diabetes interpretation based on 75g one-step and 50g/100g two-step diagnostic thresholds; Carpenter-Coustan and NDDG threshold comparison.
Prepare for your next consultation based on the screening test type, result, and ultrasound findings; this tool does not generate a new numerical risk.
Second trimester detailed (Level II) ultrasonography guide; Anatomical rubric and result interpretation according to ISUOG standards.
Official sources of the international obstetric and maternal-fetal medicine authorities (external links).
American College of Obstetricians and Gynecologists — Practice Bulletins, Committee Opinions, Clinical Consensus documents.
Royal College of Obstetricians and Gynaecologists — Green-top Guidelines and clinical standards.
National Institute for Health and Care Excellence—antenatal/intrapartum guidelines and cost-effectiveness analyses.
Society for Maternal-Fetal Medicine — Consult Series, clinical position statements and expert opinions.
Cochrane Pregnancy and Childbirth Group—systematic reviews and meta-analyses.
World Health Organization — global guidelines for antenatal care, maternal health and obstetric services.
Wolters Kluwer — continuously updated evidence-based clinical topic reviews (subscription required).
U.S. National Library of Medicine — biomedical literature search engine; Free full texts via PMC.
Last updated: .